SCHEMBL744218

SCHEMBL744218

CCOCc1ccc(N2CCCC3(CCN(S(=O)(=O)c4ccccc4Cl)CC3)C2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 14/20 0.52
CYP2C19 P33261 10/20 0.52
CYP2C9 P11712 10/20 0.52
CYP1A2 P05177 10/20 0.52
TSHR P16473 7/20 0.52
ALDH1A1 P00352 7/20 0.52
CYP2D6 P10635 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.48
CHRM4 P08173 1/20 0.45
USP2 O75604 8/20 0.44
MAPK1 P28482 4/20 0.44
HIF1A Q16665 4/20 0.44
HSD17B10 Q99714 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
CCR1 P32246 1/20 0.43
RECQL P46063 1/20 0.42
HPGD P15428 2/20 0.42
ALOX15 P16050 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL746711 0.84 CYP2C9 (0.48) CYP3A4CYP2C19CYP2C9CYP1A2TSHR
SCHEMBL743532 0.81 LIPE (0.57) CHRM4MAPK1CCR1
SCHEMBL3742918 0.79 LIPE (0.63) MAPK1CCR1
SCHEMBL744989 0.79 CYP3A4 (0.57) CYP3A4CYP2C19CYP2C9CYP1A2TSHR
SCHEMBL745542 0.76 CYP2C9 (0.52) CYP3A4CYP2C19CYP2C9CYP1A2TSHR
SCHEMBL746622 0.74 CCR1 (0.44) CYP3A4CYP2C19CYP2C9CYP1A2TSHR
SCHEMBL744705 0.73 CYP1A2 (0.47) CYP3A4CYP2C19CYP2C9CYP1A2TSHR
SCHEMBL746534 0.73 CYP3A4 (0.48) CYP3A4CYP2C19CYP2C9CYP1A2TSHR
SCHEMBL744430 0.73 LIPE (0.68) CYP3A4CYP2C19CYP2C9CYP1A2TSHR
SCHEMBL745718 0.72 CYP2C9 (0.46) CYP3A4CYP2C19CYP2C9CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430023-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-03-21 EP disclosed
WO-2010130665-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-18 WO disclosed